Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,099,336
+$868,380 QoQ
Shares Held
18,213
+253.4% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#180
of 313 holders
Holding Since
Dec 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Magnetar Financial LLC holds $120,812,551 across 42 Biotechnology names. XENE ranks #4 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
761,911 | $53,829,012 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
399,123 | $52,975,594 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
56,082 | $1,470,469 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
18,213 | $1,099,336 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,340 | $835,543 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
30,337 | $818,492 | |
| 7 | IMNM |
Immunome Inc.
|
32,589 | $690,560 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
1,911 | $639,783 |
All Filings in XENE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,099,336 | 18,213 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $230,956 | 5,153 | Shares | Sole | 2026-02-17 | |
| 2024-12-31 | $210,229 | 5,363 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||